800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
Sponsored| Name | Address | City |
|---|---|---|
| Community Medical Services Minot | 300 30th Ave NW Suite D | Minot |
| Cornerstone Addiction Services | 1705 4th Avenue NW | Minot |
| Dakota Boys and Girls Ranch | 6301 19th Avenue NW | Minot |
| North Central Human Services Center | 400 22nd Avenue NW | Minot |
| Ron Stanley Counseling Services | 2959 79th Street NW | Lansford |
No results found!
Medication treatment for opioid use disorder in Minot
Minot sits at the center of north central North Dakota, and for years it anchored the state’s earliest access to clinic-based opioid treatment. Ward County residents can reach both opioid treatment programs, which dispense methadone on site, and office-based prescribers who treat opioid use disorder (OUD) with buprenorphine or naltrexone. Because North Dakota is largely rural, telehealth also fills gaps for people in the surrounding counties who cannot easily drive in each day. The listings on this page show current options near you, and the helpline can talk through a first step if you are not sure where to start.
What treatment looks like: three medications, two settings
Three medications are approved to treat OUD, and understanding them makes the listings easier to read. Methadone is a full opioid agonist that steadies withdrawal and cravings; for OUD it is provided only through a licensed opioid treatment program (OTP), not a regular pharmacy. Buprenorphine, including the buprenorphine-naloxone combination sold as Suboxone and long-acting injectable forms such as Sublocade, is a partial agonist with a ceiling that lowers overdose risk. Naltrexone, including the monthly Vivitrol injection, blocks opioid effects entirely and is started only after a person has been off opioids for a set time.
Setting matters as much as medication. An OTP dispenses methadone daily at first, with take-home doses added as treatment stabilizes. Office-based opioid treatment (OBOT) means a clinician prescribes buprenorphine or naltrexone in a regular medical office, and you fill it at a pharmacy. Since 2023, any provider with a standard DEA registration can prescribe buprenorphine, which has widened where you can get it. If you want to weigh the trade-offs, how methadone and Suboxone compare is a useful starting point, and there is more detail on how methadone works day to day. Which option fits is a decision to make with a clinician.
Starting treatment: what to expect at your first visit
The first step is usually an intake assessment, where a clinician reviews your history and confirms a diagnosis before treatment begins. Bring an ID and any insurance information if you have it, though not having insurance does not stop you from being assessed. Most of North Dakota’s illicit opioid supply now involves fentanyl, which changes the timing of a buprenorphine start: beginning Suboxone too soon after fentanyl can trigger sudden, severe withdrawal (precipitated withdrawal), so a clinician plans the first dose with you rather than rushing it. Methadone induction happens inside the OTP and does not carry that same timing problem. If fentanyl is part of your situation, treatment approaches for fentanyl explains what to raise at intake. For a broader view of the process, see opioid treatment overall.
Take-home doses, telehealth, and current rules for the region
For people around Minot who face long winter drives, the rules on take-homes and telehealth are what make treatment workable. Federal rules updated in 2024 (42 CFR Part 8) expanded take-home methadone to as much as a 28-day supply for patients who are stable in treatment, on a graduated schedule earlier on, with eligibility decided by the program. Those same rules allow treatment to start by telehealth and authorize mobile medication units. As of July 2026, buprenorphine can be started through telehealth, including by phone in many cases, without a prior in-person visit; those flexibilities run through the end of 2026 and are still being finalized, so confirm current options with a provider. Methadone for OUD remains dispensed through an OTP. Staying with a steady dose matters, and why consistent dosing helps covers the reasoning if you are transferring in or restarting.
Paying for treatment in North Dakota
Cost is often the first worry, so start here. North Dakota Medicaid covers medications for opioid use disorder, including OTP-dispensed methadone and buprenorphine, under its MOUD benefit. The Medicaid Expansion population is administered by Blue Cross Blue Shield of North Dakota, so if you are enrolled through expansion your care runs through that network. Private insurance and Medicare also cover MOUD in most cases, and OTPs commonly offer self-pay or sliding-scale arrangements when you are uninsured. Coverage details and any prior-authorization steps vary by plan, so ask a provider on this page or the helpline to confirm what applies to you before your first visit.
The opioid picture in Ward County and North Dakota
North Dakota records fewer overdose deaths than most states, but the trend has worsened and the drug supply has shifted. Statewide, unintentional overdose deaths rose about 48 percent between 2019 and 2023, peaking at 135 in 2022 before falling to 113 in 2023, according to the North Dakota Department of Health and Human Services. Fentanyl now drives most of that loss: it was present in 77 percent of overdose deaths in 2023, up from 42 percent in 2019. County-level figures for Ward County are not published separately, and the highest death rates in the state are in Mountrail, Sioux, and Benson counties, so these numbers describe the statewide context rather than Minot alone. Behind each figure is a person, and effective medication treatment exists locally; the point of this data is to show why getting to a first step matters. You can read more about opioid addiction and how treatment helps.
Reentry and justice-involved treatment: a local priority
In Minot, the most developed local response centers on people leaving incarceration, a group at very high overdose risk in the first weeks after release. The Ward County Opioid Task Force, established by the Ward County Commission and led by First District Health Unit, has directed county and City of Minot opioid-settlement funds into a Medication for Opioid Use Disorder program at the Ward County Detention Center, continuing treatment for people who enter already enrolled and connecting others to care. If you or someone you love is coming out of the detention center, ask intake staff or a provider on this page how to keep methadone or buprenorphine going without a gap, since continuity through that transition is what protects against overdose. For pregnant patients, medication treatment is the recommended standard of care during pregnancy, and starting or staying in treatment is safer for both parent and baby than stopping; methadone and pregnancy walks through what to expect. Treatment records are protected by confidentiality rules, and guidance for families can help loved ones support someone without overstepping.
Naloxone and overdose safety
Naloxone, the medication that reverses an opioid overdose, is widely available in North Dakota. A pharmacist can dispense it directly, and North Dakota Health and Human Services issued a standing order that lets enrolled pharmacies provide over-the-counter naloxone at no cost to Medicaid members. The state’s Behavioral Health Division also mails free two-dose kits on request, and many local public health units and primary care providers keep it on hand. North Dakota’s Good Samaritan law offers some protection to people who call for help during an overdose. Keeping naloxone nearby is a practical safeguard for anyone in treatment or around opioid use, and a return to use is a common, manageable part of recovery rather than a failure. See more on recognizing and responding to overdose.
Common questions about treatment in Minot
Do I have to go to a clinic every day for methadone?
At the start, yes: methadone for OUD is dispensed at an opioid treatment program, often daily. As you stabilize, federal rules let programs approve take-home doses, up to a 28-day supply for patients who are stable, so daily visits are usually temporary.
Can I start Suboxone by telehealth from home?
Often, yes. As of July 2026, buprenorphine can be started through telehealth, including by phone in many situations, without a prior in-person visit. These rules run through the end of 2026 and are still being finalized, so confirm what is current with the provider you choose.
What is the difference between methadone and Suboxone?
Methadone is a full opioid agonist dispensed through a clinic; buprenorphine, in Suboxone, is a partial agonist that can be prescribed in an office and filled at a pharmacy. Each fits different needs, and the choice is best made with a clinician. A fuller set of answers to common questions may help.
Is methadone just trading one addiction for another?
No. Taking a prescribed, steady medication that lets you function is treatment of a chronic condition, not continued addiction. Whether long-term medication can lead to dependence is a fair question, addressed in this explainer on methadone and dependence.
Does North Dakota Medicaid pay for treatment?
Yes. North Dakota Medicaid covers medications for opioid use disorder, including methadone through an OTP and buprenorphine, and the Expansion population is administered through Blue Cross Blue Shield of North Dakota. Confirm plan specifics and any prior authorization with a provider or the helpline.
Last reviewed and disclosures
Last reviewed July 2026.
Sources
- North Dakota Department of Health and Human Services, Unintentional Drug Overdose Deaths, 2024 Legislative Report (data through 2023-2024).
- North Dakota Department of Health and Human Services, ND Medicaid Billing and Policy Manual: Medication for Opioid Use Disorder (updated January 2026).
- North Dakota Department of Health and Human Services, statement on expanded no-cost naloxone access for ND Medicaid members, and ND Board of Pharmacy naloxone guidance.
- Ward County Opioid Task Force / First District Health Unit and City of Minot, collaborative Medication for Opioid Use Disorder plan (2024-2025).
- U.S. Drug Enforcement Administration and U.S. Department of Health and Human Services, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities (effective January 1, 2026 through December 31, 2026) and Expansion of Buprenorphine Treatment via Telemedicine Encounter final rule.
- Substance Abuse and Mental Health Services Administration (SAMHSA) and Federal Register, 42 CFR Part 8 final rule (2024); SAMHSA and FDA MOUD overview.
Methadone Centers is a treatment-discovery and education resource, not a medical provider. We do not provide medical advice, diagnosis, or treatment, and the information here is not a substitute for care from a qualified clinician.
The helpline connected to this site is a sponsored resource. Calls may be answered by a paid treatment provider. Using the helpline carries no obligation, and you can contact any provider listed on this page directly.